Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Enrollment Completed in C-BEYOND Phase 3 Trial with More Than 880 HCV Treatment-Naïve Patients in US and Canada C-BEYOND Topline Results Expected Mid-2026 C-FORWARD Phase 3 Trial, Conducted Outside ...

Shield AI took its drones from the ‘Batcave’ to the battlefield. Now the $5.6 billion defense-tech startup’s new CEO says it’s at an inflection point

After eight months spent tweaking its surveillance drone in Ukraine, demand for Shield AI’s V-BAT is ramping up in Europe and ...

Crypto Hedge Funds Just Got Crushed--And October Was the Breaking Point

A brutal mix of Trump-driven chaos, vanishing liquidity, and collapsing altcoins is forcing funds to rewrite their entire ...
Investing.com Australia

10 Best German Stocks for 2026, According to Kepler Cheuvreux

Investing.com -- Germany’s stock market offers compelling opportunities for investors in 2026, with several companies poised for growth despite macroeconomic challenges. Kepler Cheuvreux has ...